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Abstract In our search for genes up- or down-regulated genes 
in the mdx mouse model for Duchenne muscular dystrophy, we 
isolated a down-regulated mitochondrial DNA clone. In addition 
to this clone, all protein-coding mitochondrial genes tested had 
tissue-specific and age independent down-regulated expression. 
This implied mechanisms at the RNA level since no change in the 
mitochondrial DNA contents were detected. Cytocbrome c oxi- 
dase activity showed the same range of down-regulated expres- 
sion. These data provide a molecular basis for energetic metabo- 
lism modifications in mdx mice. 
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1. Introduction 
The mdx mouse is a puzzling model for severe Duchenne 
muscular dystrophy, which is reported to be caused by muta- 
tions in the dystrophin gene [16,17]. In the mdx mouse, a point 
mutation [2] created a premature stop codon [24] but, unlike 
humans, this animal has almost no motile alterations. In fact, 
between 3 and 4 weeks of age, mdx mice undergo a temporary 
major DMD-like crisis with muscle fiber degeneration and ne- 
crosis [9,10,19]. Regeneration and recovery are evident by 5 to 
6 weeks and muscle fibers are somehow protected from further 
definitive necrosis. One exception concerns the diaphragm 
which shows a characteristic DMD histological pattern of ne- 
crosis and connective tissue proliferation in the aging mdx 
mouse [25]. 
Very little is known about the cascade of events starting with 
dystrophin deficiency and ending with dramatically progressive 
DMD, and it is not yet understood how the mdx mouse can 
largely compensate for dystrophin deficiency. We have devel- 
oped a strategy based on the assumption that, regarding the 
drastic modifications that occur in skeletal muscles, the absence 
of dystrophin creates cellular signals that are important enough 
to interfere with transcription of a significant population of 
genes. To identify such up- or down-regulated genes, we con- 
structed a cDNA mdx mouse muscle library and differentially 
screened it with probes from mdx mouse muscles and control 
*Corresponding author. Fax: (33) 67 04 21 40. 
Abbreviations: DMD, Duchenne muscular dystrophy; GAPDH, glycer- 
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muscles. A down-regulated clone was isolated in md.x mouse 
skeletal muscle. This clone contained 80% of the ATPase 6 gene 
from mitochondrial DNA. Further analysis showed that down- 
regulation affected other mitochondrial RNAs. This under- 
expression was found to be specific to skeletal muscles and 
brain, but not dependent on age, and paralleled the down- 
regulated activity of partially mitochondrial encoded cyto- 
chrome c oxidase. 
2. Materials and methods 
2.1. Tissues and RNA extraction 
Tissues were dissected from 3-month-old C57BL/lOmdx and C57BLl 
1OScSn control male mice, frozen in liquid nitrogen and stored at 
-80°C. Muscle samples (posterior legs and the bottom part of the back) 
were checked by histology and immunofluorescence with an anti- 
dystrophin monoclonal antibody [21]. Total RNAs were extracted 
using a guanidine isothiocyanate method [5], from a l-to-4 g pool of 
tissues from 5 to 10 animals. RNA concentration and purity were 
assessed by measuring absorbance at 260,270 and 280 nm [26] and gel 
electrophoresis. 
2.2. Differential screening procedures 
A Uni-Zap XR (Stratagene) phage library, derived from 3-month-old 
mdx mouse skeletal muscles, was plated at low density (4 to 5 colonies/ 
cm’) and transferred onto four nylon membrane replicate sets. The first 
and third replicates were hybridized with the mdx probe and the second 
and fourth replicates were hybridized with the control probe. “P-la- 
beled single strand cDNA probes (1 x 10’ to 5 x 10’ dpm/pg) were 
prepared from I pg of poly(A’) RNA from 3-month-old mdx and 
control mouse skeletal muscles and column purified according to Sam- 
brook et al. [23]. Clones showing differential hybridization signals, on 
both duplicate membranes and with different X-ray film exposures, 
were recovered as pBluescript SK phagemids according to the supplier’s 
protocol. Sequence determinations were performed on both strands 
using T3 and T7 primers and the Taq Dye Primer Cycle Sequencing Kit 
(Applied Systems at Gkntthon, Evry, France). Sequences were com- 
pared to database sequences with the Blast program. 
2.3. Northern blots 
Total RNAs were size-fractionated in denaturing 1% agarose gels in 
the presence of ethidium bromide (25 &ml) and transferred to nylon 
membranes as described by the supplier (Amersham). Double-strand 
cDNA probes were made-from P&-prepared DNA fragments that 
were la-“PldCTP labeled bv random urimine. S14 inserts were T7-SK 
primeb; otter mitochondriai DNA prdbes were generated by PCR with 
the pAM1 DNA template, a plasmid coding for the complete mouse 
mitochondrial genome (generous gift of Dr. Patrick Lestienne) and the 
following primers: 5’-CGCCATAGCCTTCCTAACATT-3’/5’-ATG- - _ 
GTGGTACTCCCGCTGTAA -3’ (NDl); 5’-AATCGTTGATTATT- 
CTCAACC-3’/5’-TAGGTTGGTTCCTCGAATGTG -3’ (COI); 5’-C- 
CCATTCCAACTTGGTCTACA-3’/5’-AATTATTGAAGCAGATC- 
AGTT -3’ (COII); 5’-AACTAGATACATCAACATGAT-3’/5’-GGG- 
GTTTTTACTTTTATGGTT -3’ fATPase 8): S’CAAACTCATGCA- 
TATCACATA-3W-GGAAAAGiCAGATfACGTCTA -3’ (COIII); 
S-CCCTCCTTCCAACATACTCC-3’/5’-TTTGGTTGGTTGTCTT- 
GGGTT -3’ (ND6); S-CCTCCTGCCCCATCCAACAT-3’/5’-CGAT- 
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A4TTCCTGAGATTGGTA -3’ (cyt b). GoldStar DNA polymerase 
(1:urogentec) was used in 30 cycle reactions (1 min/95”C, 1 min/50”C 
and 1 min/72”C). Ribosomal 18s RNA oligonucleotides were 
b-32P]dATP kinased according to the standard procedure. All probes 
were purified through G50 spin-columns. The hybridizations were car- 
rl:d out overnight in 50% formamide, 5 x SSPE, 5 x Denhard’t solution, 
1’6 SDS and 100 mg/ml salmon sperm DNA, at 42°C. The membranes 
P ere washed in 0.1 x SSPE, 0.2% SDS at 5O”C, exposed to Amersham 
fiyperfilms for autoradiography and scanned with a phosphor imager 
a lalyser (Fuji Bas 1000) for quantification with the MacBas program 
(I ‘uji). Data were averaged and variance was estimated according to the 
s,andard error. The amounts of RNAs (routinely 10 to 20 pug) were 
r, jrmalized by re-probing the same lanes or probing half of the lanes 
v ith GAPDH and/or 18s rRNA. No significant differences were noted 
t :tween these two internal standards. 
_ 4. Mitochondrial enzyyme assays i 
100 mg of diaphragm slices were homogeneized in 10 volumes of 10 
I LM phosphate buffer (pH 7.5) on ice. Citrate synthase and cytochrome 
c oxidase activities were measured in increasing quantities ofdiaphragm 
1 amogenates in the presence of 1 mM lauryl-maltoside, at 25°C. Cyto- 
( nome c oxidase activity was measured, at 550 nm, as the oxidation 
r lte of reduced cytochrome c by diaphragm homogenates [22]. Citrate 
: lnthase activity was initiated by the addition of 0.5 mM oxaloacetic 
; ;id and monitored at 412 nm for 6 min in the presence of excess 
: lbstrate (0.1 mM 5,5’-dithio-bis(-2-nitrobenzoic acid)) and cofactor 
f I.3 mM acetyl coA). 
3. Results 
.I. S14 clone selection by differential screening 
Three thousand clones of a 3-month-old md,x mouse muscle 
t DNA library were differentially screened with probes pre- 
! ‘ared with muscles from 3-month-old mdx and control mice. 
‘i’hree clones showing differential hybridization signals, be- 
I ween mdx and control probes, were isolated. The investigation 
L arried out with one clone, designated S14, is reported here. In 
the library screening, this clone exhibited a lower hybridization 
signal with the mdx probe than with the control probe (Fig. 
1A). It contained a 560 bp insert and its expression, detected 
by Northern blot, in muscles of 3-month-old md,x mice as com- 
pared to control is shown in Fig. 1B. The size of the main 
hybridized RNA band was approximately 800 bp. Quantifica- 
tion revealed twofold lower expression in mdx mouse muscle 
(ratio contro1lmd.u = 2.12 + 0.12; n = 11). Sequencing and re- 
search in Genebank and Swissprot databases indicated that 
clone S14 represented about 80% of the ATPase 6 gene. This 
is a mitochondrial gene encoding subunit 6 of the ATPase 
complex, located from positions 7927 to 8606 on the 16 295 bp 
circular mitochondrial mouse genome [ 11. S14 encompassed the 
region from position 8045 to position 8605: below it is referred 
to as the ATPase 6 probe. 
3.2. Down-expression probed with ATPase 6 concerns the other 
mitochondriul RNAs 
In the mitochondrial genome, each complete DNA strand is 
transcribed as one polycistronic RNA chain before further 
cleavages at the tRNA level [6]. This explained why the size of 
the band we detected on Northern blots corresponded to a 
mRNA encoded by the two overlapping ATPase 6 and ATPase 
8 genes [l]. To determine whether transcripts down-regulated 
in mds mouse muscle were limited to this ATPase 618 RNA, 
eight probes along the mitochondrial genome were synthesized 
by PCR and assayed in comparative Northern blots (Fig. 2A). 
The same twofold under-expression (ratio control/ 
md.y = 1.95 & 0.12; n = 29) was reproducibly observed in md.x 
mouse muscles with all mitochondrial probes for the main 
bands and larger bands corresponding to characteristically 
longer premature mitochondrial transcripts. One complete hy- 
bridization pattern is shown in Fig. 2B with the NADH dehy- 
A I3 
Mdx C 
s14 
GAPDH 
Mdx probe C probe 
?g. 1. S14 clone selection. Down-regulation observed in the differentia 
B). Control: C. 
11 screening (A) of the S14 clone (arrow) was confirmed on Northern blots 
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Fig. 2. Quantitative Northern blot analysis of eight mitochondrial gene 
transcripts from mdx and control muscles. (A) RNA blots were com- 
paratively analyzed with the probes listed on the right; the apparent 
approximate transcript sizes are presented on the left. (B) Complete 
hybridization patterns shown with ND 6 probe, after over-exposition 
to highlight the two minor larger bands. Control: C. 
drogenase 6 probe. We concluded that down-regulation, ini- 
tially detected with the ATPase 6 probe, actually involved all 
mitochondrial RNA transcripts we detected, regardless of their 
maturation status. 
3.3. mdx mouse muscle does not contain less mitochondrial DNA 
than control mouse muscle 
One explanation for the down-regulated expression of mito- 
chondrial RNAs in mdx mouse muscle could have been a reduc- 
tion in the amount of mitochondrial DNA. We tested this 
hypothesis by comparing mitochondrial DNA contents in mdx 
Mdx C 
Limb 
1 month 
Mdx C 
Limb 
3 months 
Mdx C 
I 
Mdx C 
and control mouse muscles. Detection was made by Southern 
blots of Hind111 digested genomic DNA, prepared from mus- 
cles, hybridized with the ATPase 6 used as mitochondrial DNA 
probe, and a nuclear DNA probe to normalize the signals. The 
nuclear probe was a 1 kb XhoI-Hind111 cDNA fragment coding 
for the mitochondrial ATPase a subunit. Quantification of 
ATPase 6 probe hybridization signals (not shown) did not show 
any significant differences between mdx and control mice after 
normalization by the nuclear probe (ratio control/ 
mdx = 0.97 + 0.10; n = 3), demonstrating no change in the 
amount of mitochondrial DNA in mdx mouse skeletal muscle. 
The same result was obtained with another mitochondrial 
probe, derived by PCR from cytochrome b DNA and two other 
nuclear probes, p actin and calsequestrin. Down-regulated ex- 
pression of mitochondrial RNA could therefore not be the 
result of less mitochondrial DNA in mdx mouse muscles, but 
implies a regulatory mechanism at the RNA level. 
3.4. Down-regulation of mitochondrial RNAs is tissue specl$c 
and age independent 
Dystrophin transcripts are normally expressed in a tissue 
specific manner (for a review see [13]) and the impact of dystro- 
phin deficiency is only particularly severe in the diaphragm of 
the aging mdx mouse [25]. Moreover, a very characteristic re- 
generation crisis affects approximately l-month-old mdx 
mouse muscle [8,19]. It was thus of interest to test the age 
dependance and tissue specificity of down-regulation of mito- 
chondrial RNAs. Fig. 3 shows Northern blots from mdx and 
control mice, probed with ATPase 6 and made from different 
tissues; (i) l-, 3- and 9-month-old limb muscles, diaphragm, 
heart and brain, tissues where dystrophin RNAs are normally 
transcribed, and (ii) liver which does not contain dystrophin 
transcripts. In limb muscles, the same twofold down-regulation 
found at 3 months was measured at 1 month (ratio control/ 
mdx = 2.10 f 0.07; n = 3) and 9 months (ratio control/ 
mdx = 1.92 ? 0.10; n = 5) indicating no age dependence of 
down-regulated expression of mitochondrial RNAs. The two- 
fold under-expression observed in limb muscles from the mdx 
mouse was detected in diaphragm (ratio control/ 
mdx = 2.20 f 0.16; n = 3) and brain (ratio control/ 
mdx = 1.80 f 0.12; n = 8), but not found in the liver (ratio con- 
trollmdx = 1.03 ? 0.11; n = 3) or heart (ratio control/ 
Mdx C Mdx C 
Heart IJraio 
3 months 3 months 
Mdx C 
Liver 
3 months 
A’l’hse 6 
Fig. 3. Age independance and tissue specificity of the mitochondrial RNA down-regulation. The levels of expression of mitochondrial RNAs were 
compared in mdx and control mice by ATPase 6 Northern blot analysis in limb muscles (l-, 3- and 9-month-old), diaphragms, hearts, brains and 
liver, using 10 pg of total RNA for the three former tissues and 30 pg for the two latter tissues. Only heart and liver did not present lower ATPase 
6 expression. Control: C. 
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Fig. 4. Comparison of cytochrome c oxidase activities in mdx and 
.ontrol mouse diaphragms. Cytochrome c oxidase activities (A) were 
normalized with the citrate synthase activities (B). Assays were per- 
‘armed in increasing quantities of diaphragm homogenates and ex- 
lressed relative to the protein concentrations of these homogenates. 
rhree determinations (Bio-Rad reagent) were carried out for each pro- 
‘ein concentration and the difference between estimations was less than 
‘0%. 
ndx = 1.00 f 0.12; n = 3). This shows the strict tissue specific- 
ty of mitochondrial RNA down-regulation. It did not com- 
;>letely match the tissue specificity of dystrophin and was not 
:nodulated by the difference between diaphragm and other skel- 
:tal muscles concerning damage caused by a lack of dystrophin. 
55. Down-regulation of mitochondrial RNAs parallels down- 
regulation of a mitochondrial enzyme activity 
To determine the consequences of the twofold down-regula- 
211 
tion of mitochondrial RNAs at the translation level, the activity 
of the cytochrome c oxidase complex containing three of the 
main mitochondrial DNA encoded enzymes, cytochrome 
oxydases I, II and III, was compared in mdx mouse and control 
muscles. Three-month-old diaphragms were chosen because 
these muscles present a homogeneous distribution of fast and 
slow fibers [16] (Pons, personal communication), thus eliminat- 
ing artifactual differences from the tissue samples. As shown 
in Fig. 4, this activity was standardized according to the activity 
of citrate synthase, a nuclear DNA encoded enzyme function- 
ing in mitochondria. The same twofold lower difference (ratio 
controllmdx = 1.80 + 0.20; n = 3; calculated at 50% activity), 
detected in the expression of mitochondrial RNAs, was meas- 
ured for cytochrome c oxidase activity in mdx mouse muscles. 
Down-regulation of mitochondrial RNAs could thus directly 
induce quantitatively similar down-regulation at the translated 
product level. 
4. Discussion 
Through differential screening, we isolated a mitochondrial 
clone encompassing 80% of the ATPase 6 gene and down- 
regulated in mdx mouse skeletal muscles. Extension of ATPase 
6 down-regulation in mdx mouse skeletal muscles to all mature 
RNAs and their precursors is in agreement with the specificities 
of mitochondrial transcription: one promoter controls tran- 
scription of each mitochondrial DNA strand in one long pre- 
mature polycistronic transcript [29]. Since the amount of mito- 
chondrial DNA remained unchanged in the mdx mouse and the 
same twofold under-expression was found for all mitochondrial 
genes tested, the simpliest explanation would be transcription 
regulation affecting all transcripts in the same way. 
There are at least two arguements that favor a highly signif- 
icant impact of the observed down-regulation. (i) The twofold 
difference could be enough to modulate some aspects of the 
cellular activity since this down-regulation did not concern only 
one gene, but rather a complete set of genes cooperating in the 
very essential oxidative phosphorylation pathway. It is likely 
that such key genes for ATP production cannot undergo ma- 
nyfold deregulation, especially in tissues such as brain and 
muscle, which rely more on mitochondrial ATP production. 
Variations in the expression of mitochondrial genes were thus 
reported to be 2- to 4-fold during myogenic differentiation [30], 
and 1.5- to g-fold in more extreme situations such as mitochon- 
drial myopathies [15] and cancer cells [28]. In addition, the 
general trend in mdx and DMD muscles of a shift towards 
oxidative slow-type muscle fibers [3,18,20,25], richer in mito- 
chondrial DNA and RNA [31], partially reduces the decrease 
in the overall mitochondrial RNA content here. (ii) The second 
element is under-expression of the encoded proteins. It cannot 
be ruled out that the twofold lower cytochrome c oxidase activ- 
ity in mdx muscles, an essential enzyme of the respiratory chain, 
was due to its nuclear encoded subunits. However, the fact that 
the same twofold difference was noted in enzymatic activity and 
RNA expression suggests that down-regulation of mitochon- 
drial RNAs leads to a parallel under-expression of the encoded 
proteins. 
Our data suggest a direct causal relationship between the lack 
of dystrophin and down-regulation of mitochondrial RNA 
transcripts, instead of a secondary effect such as non-specific 
consequences of regeneration or necrosis. First, this down- 
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regulation was found at l-month-old, when the muscle fibers 
go through a major degeneration/regeneration crisis, and at 3- 
and 9-month-old, when fiber regeneration is complete. Second, 
it affected limb and diaphragm muscles in the same manner, 
although only the latter reproduced strong DMD-like muscle 
damage [25]. The altered mitochondrial genetic expression was 
thus in line with the lack of dystrophin in skeletal muscles, 
regardless of their ages or physiological status. Third, the brain, 
which is not known to show any degeneration or necrosis, 
presented the same down-regulation as muscles. In the mdx 
mouse, both brain and muscles fail to express dystrophin tran- 
scripts. Moreover, the fact that the situation in liver provided 
a good negative control was in full agreement with our hypoth- 
esis, since this tissue does not normally express dystrophin. 
However, the non-deregulation of mitochondrial transcripts in 
mdx hearts indicated a cardiac specific phenomenon. The heart, 
as skeletal muscles and brain, normally expresses dystrophin 
transcripts and is very reliable for mitochondrial energy pro- 
duction. However, it oversteps the l-month-old necrosis phase 
and, more generally, cardiac function seems to be partly pro- 
tected in DMD patients since cardiac tissue resists the lack of 
dystrophin much longer than skeletal muscles [14]. One expla- 
nation for this cardiac adaptation could be the existence of a 
short protein product of the dystrophin gene, named DP71, 
which has been found in heart but not in skeletal muscles [ 121. 
So far very few modifications in mitochondria from muscles 
lacking dystrophin have been reported. However, Cullen and 
Watkins [93 have observed unexplained ultrastructural changes 
in DMD and mdx mouse mitochondria. These changes could 
be correlated with the down-regulated expression of mitochon- 
drial genes. Very recently, energy metabolism measurements 
have highlighted an impaired oxidative metabolism in mdx 
mouse skeletal muscles [ 111. Our data provide a molecular basis 
for the defective regulation of cellular energy production in the 
mdx mouse and could be explained by a cytoskeleton role. On 
one hand, one possible function of dystrophin is in anchorage 
of the cytoskeleton to the sarcolemma [27]; on the other hand, 
the mitochondrial matrix is likely associated with the cytoskel- 
eton [4] and some of the mitochondrial mRNAs could belong 
to the growing known population of mRNAs cytoskeleton- 
dependent in terms of their transport and translation [7]. The 
absence of dystrophin could thus induce some reorganization 
of the cytoskeleton, which could deregulate the expression of 
mitochondrial genes. 
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